89bio Inc. (ETNB)
6.38
0.10 (1.59%)
At close: Jan 15, 2025, 1:24 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -142.19M | -102.03M | -90.12M | -49.50M | -57.42M | -16.18M |
| Depreciation & Amortization | 50.00K | 65.00K | 79.00K | 60.00K | 17.00K | 6.00K |
| Stock-Based Compensation | 16.11M | 10.36M | 8.68M | 3.81M | 389.00K | 108.00K |
| Other Working Capital | 4.57M | 4.90M | -1.53M | -2.17M | 1.46M | 1.13M |
| Other Non-Cash Items | -3.94M | -41.00K | 1.48M | 498.00K | 30.60M | 979.00K |
| Deferred Income Tax | 127.00K | n/a | -150.00K | -69.00K | 20.00K | -20.00K |
| Change in Working Capital | 657.00K | 10.56M | 3.25M | -1.04M | 937.00K | 2.63M |
| Operating Cash Flow | -129.19M | -81.09M | -76.78M | -46.24M | -25.46M | -12.47M |
| Capital Expenditures | -4.00K | -7.00K | -63.00K | -126.00K | -139.00K | -39.00K |
| Acquisitions | n/a | 33.94K | -7.22K | 106.71K | n/a | n/a |
| Purchase of Investments | -341.15M | -152.70M | -141.20M | -118.89M | n/a | n/a |
| Sales Maturities Of Investments | 218.13M | 118.76M | 148.42M | 12.19M | n/a | n/a |
| Other Investing Acitivies | n/a | -33.94K | 7.22K | -106.71K | n/a | n/a |
| Investing Cash Flow | -123.02M | -33.94M | 7.16M | -106.83M | -139.00K | -39.00K |
| Debt Repayment | 2.96M | n/a | 19.95M | n/a | n/a | 100.00K |
| Common Stock Repurchased | 268.00K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 13.58M | 834.00K | 144.00K | 244.00K | 20.00M | 23.66M |
| Financial Cash Flow | 513.11M | 117.83M | 23.87M | 157.92M | 107.70M | 23.77M |
| Net Cash Flow | 260.91M | 2.80M | -45.75M | 4.85M | 82.10M | 11.26M |
| Free Cash Flow | -129.19M | -81.10M | -76.84M | -46.37M | -25.60M | -12.51M |